Clearmind Medicine receives approval to continue phase I trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St choppy as megacap losses offset chip gains before Fed decision
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: CMND) | Delayed: 6.10 +0.13 (2.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.97 | 52 Week High | $ | |||
| Open | $5.98 | 52 Week Low | $ | |||
| Day High | $6.10 | P/E | N/A | |||
| Day Low | $5.98 | EPS | $ | |||
| Volume | 1,179 | |||||
